(Q42183463)
Statements
Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major (English)
Lee Lee Chan
Amal El-Beshlawy
Yesim Aydinok
Hishamshah Ibrahim
Chi-Kong Li
Vip Viprakasit
Mohsen S Elalfy
Antonis Kattamis
Gillian Smith
Dany Habr
Gabor Domokos
Bernard Roubert
22 January 2012
1 reference
1 reference
1 reference